ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,187.70
      0.13%
      US Tech 100
      17,617.63
      0.04%
      Dow Jones
      38,884.26
      0.08%
      Brent Oil
      82.715
      -0.18%
      Bitcoin
      62,567.87
      0.37%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Ikena Oncology Inc (IKNA)

      7. Ikena Oncology Inc (IKNA) News

      IKNA

      Ikena Oncology (IKNA)

      Ikena Oncology Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IKNA
      DateTimeSourceHeadlineSymbolCompany
      12:51PMiHub NewswireFeaturedCannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa
      04/10/20248:00AMGlobeNewswire Inc.Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:IKNAIkena Oncology Inc
      03/12/20248:00AMGlobeNewswire Inc.Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:IKNAIkena Oncology Inc
      03/05/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
      03/05/20244:01PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
      02/27/20248:00AMGlobeNewswire Inc.Ikena Oncology to Participate in TD Cowen 44th Annual Health Care ConferenceNASDAQ:IKNAIkena Oncology Inc
      02/21/20244:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
      02/21/20244:15PMGlobeNewswire Inc.Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical OfficerNASDAQ:IKNAIkena Oncology Inc
      02/02/20245:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
      02/02/20245:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
      01/18/20244:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
      01/18/20244:05PMGlobeNewswire Inc.Ikena Oncology Outlines Key Priorities and Provides Corporate UpdatesNASDAQ:IKNAIkena Oncology Inc
      11/09/20237:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IKNAIkena Oncology Inc
      11/09/20237:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
      11/09/20237:00AMGlobeNewswire Inc.Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial ResultsNASDAQ:IKNAIkena Oncology Inc
      11/07/20238:00AMGlobeNewswire Inc.Ikena Oncology to Present at Multiple November 2023 Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
      10/11/20235:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
      09/25/20234:05PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:IKNAIkena Oncology Inc
      09/15/20234:05PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:IKNAIkena Oncology Inc
      09/12/20234:11PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IKNAIkena Oncology Inc
      09/11/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IKNAIkena Oncology Inc
      09/05/20238:00AMGlobeNewswire Inc.Ikena Oncology to Participate in September 2023 Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
      08/18/20234:03PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:IKNAIkena Oncology Inc
      08/18/20234:02PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IKNAIkena Oncology Inc
      08/10/20238:00AMGlobeNewswire Inc.Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate UpdateNASDAQ:IKNAIkena Oncology Inc
      08/10/20237:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IKNAIkena Oncology Inc
      08/07/20238:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
      08/07/20237:00AMGlobeNewswire Inc.Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock TransactionNASDAQ:IKNAIkena Oncology Inc
      06/30/20235:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
      06/13/20234:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IKNAIkena Oncology Inc
       Showing the most relevant articles for your search:NASDAQ:IKNA